164 related articles for article (PubMed ID: 16260749)
1. Direct interaction of the human I-mfa domain-containing protein, HIC, with HIV-1 Tat results in cytoplasmic sequestration and control of Tat activity.
Gautier VW; Sheehy N; Duffy M; Hashimoto K; Hall WW
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16362-7. PubMed ID: 16260749
[TBL] [Abstract][Full Text] [Related]
2. The human I-mfa domain-containing protein, HIC, interacts with cyclin T1 and modulates P-TEFb-dependent transcription.
Young TM; Wang Q; Pe'ery T; Mathews MB
Mol Cell Biol; 2003 Sep; 23(18):6373-84. PubMed ID: 12944466
[TBL] [Abstract][Full Text] [Related]
3. Developmental regulators containing the I-mfa domain interact with T cyclins and Tat and modulate transcription.
Wang Q; Young TM; Mathews MB; Pe'ery T
J Mol Biol; 2007 Mar; 367(3):630-46. PubMed ID: 17289077
[TBL] [Abstract][Full Text] [Related]
4. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
[TBL] [Abstract][Full Text] [Related]
5. Intermolecular masking of the HIV-1 Rev NLS by the cellular protein HIC: novel insights into the regulation of Rev nuclear import.
Gu L; Tsuji T; Jarboui MA; Yeo GP; Sheehy N; Hall WW; Gautier VW
Retrovirology; 2011 Mar; 8():17. PubMed ID: 21401918
[TBL] [Abstract][Full Text] [Related]
6. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
Chen H; He J; Fong S; Wilcox G; Wood C
J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
[TBL] [Abstract][Full Text] [Related]
7. How the sequestration of a protein interferes with its mechanism of action: example of a new family of proteins characterized by a particular cysteine-rich carboxy-terminal domain involved in gene expression regulation.
Thébault S; Mesnard JM
Curr Protein Pept Sci; 2001 Jun; 2(2):155-67. PubMed ID: 12370022
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies.
Mhashilkar AM; Bagley J; Chen SY; Szilvay AM; Helland DG; Marasco WA
EMBO J; 1995 Apr; 14(7):1542-51. PubMed ID: 7537216
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning of a novel human I-mfa domain-containing protein that differently regulates human T-cell leukemia virus type I and HIV-1 expression.
Thébault S; Gachon F; Lemasson I; Devaux C; Mesnard JM
J Biol Chem; 2000 Feb; 275(7):4848-57. PubMed ID: 10671520
[TBL] [Abstract][Full Text] [Related]
10. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation.
Boven LA; Noorbakhsh F; Bouma G; van der Zee R; Vargas DL; Pardo C; McArthur JC; Nottet HS; Power C
J Neurovirol; 2007 Apr; 13(2):173-84. PubMed ID: 17505986
[TBL] [Abstract][Full Text] [Related]
13. Luman, a new partner of HIV-1 TMgp41, interferes with Tat-mediated transcription of the HIV-1 LTR.
Blot G; Lopez-Vergès S; Treand C; Kubat NJ; Delcroix-Genête D; Emiliani S; Benarous R; Berlioz-Torrent C
J Mol Biol; 2006 Dec; 364(5):1034-47. PubMed ID: 17054986
[TBL] [Abstract][Full Text] [Related]
14. I-mfa domain proteins interact with Axin and affect its regulation of the Wnt and c-Jun N-terminal kinase signaling pathways.
Kusano S; Raab-Traub N
Mol Cell Biol; 2002 Sep; 22(18):6393-405. PubMed ID: 12192039
[TBL] [Abstract][Full Text] [Related]
15. Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator.
Desai-Yajnik V; Hadzic E; Modlinger P; Malhotra S; Gechlik G; Samuels HH
J Virol; 1995 Aug; 69(8):5103-12. PubMed ID: 7609079
[TBL] [Abstract][Full Text] [Related]
16. TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation.
Taylor JP; Pomerantz R; Bagasra O; Chowdhury M; Rappaport J; Khalili K; Amini S
EMBO J; 1992 Sep; 11(9):3395-403. PubMed ID: 1505523
[TBL] [Abstract][Full Text] [Related]
17. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression.
Modesti N; Garcia J; Debouck C; Peterlin M; Gaynor R
New Biol; 1991 Aug; 3(8):759-68. PubMed ID: 1931822
[TBL] [Abstract][Full Text] [Related]
18. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal modulatory interaction between human immunodeficiency virus type 1 Tat and transcription factor NFAT1.
Macián F; Rao A
Mol Cell Biol; 1999 May; 19(5):3645-53. PubMed ID: 10207088
[TBL] [Abstract][Full Text] [Related]
20. Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.
Schafer SL; Vlach J; Pitha PM
J Virol; 1996 Oct; 70(10):6937-46. PubMed ID: 8794337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]